Activity value 94england Buyer&Supplier,Last transaction date:
2025-06-25Address: unit 24, barker business park melmerby, ripon, hg4 5nb
Overview
Contact
Import data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for knox pharmaceuticals ltd. from 2024 to 2025.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2025, the company has completed 33 transactions, with a transaction quantity of 3219820 and a transaction weight of 0.
Product description
MEDICAMENTS CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC PURPOSES, PUT UP IN MEASURED DOSES INCL. THOSE FOR TRANSDERMAL ADMINISTRATION OR IN FORMS OR PACKINGS FOR RETAIL SALE (EXCL. CONTAINING ANTIBIOTICS, HORMONES OR STEROIDS USED AS HORMONES, ALKALOIDS, PROVITAMINS, VITAMINS, THEIR DERIVATIVES, ANTIMALARIAL ACTIVE PRINCIPLES AND BLINDED CLINICAL TRIAL KITS)
Expand
knox pharmaceuticals ltd. is england Buyer&Supplier,
and primarily engages in the import and export business of products such as tablet,pharmaceutical product,iu.
According to the 52wmb.com global trade database, as of 2025-06-25, the company has completed 11947 international trades,
with its main trading regions covering turkey,india,jamaica etc.
The core products include HS300490000000,HS30049069,HS30049099 etc,
often transported via n'djamena,port apapa, port lagos etc,
and its main trading partners are co -re -na ecza deposu diş ticaret anonim şirketi,kuzeypharma diş ticaret limited şirketi,pharmatek ecza deposu tibbi ürünler anonim şirketi.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on knox pharmaceuticals ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.